- Home
- CNEY vs HSDT Comparison
CNEY vs HSDT Comparison
Compare CNEY & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNEY
- HSDT
- Stock Information
- Founded
- CNEY 2018
- HSDT N/A
- Country
- CNEY China
- HSDT United States
- Employees
- CNEY N/A
- HSDT N/A
- Industry
- CNEY Major Chemicals
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNEY Industrials
- HSDT Health Care
- Exchange
- CNEY Nasdaq
- HSDT Nasdaq
- Market Cap
- CNEY 2.1M
- HSDT 2.5M
- IPO Year
- CNEY 2021
- HSDT N/A
- Fundamental
- Price
- CNEY $2.74
- HSDT $9.21
- Analyst Decision
- CNEY
- HSDT Hold
- Analyst Count
- CNEY 0
- HSDT 1
- Target Price
- CNEY N/A
- HSDT N/A
- AVG Volume (30 Days)
- CNEY 49.8K
- HSDT 420.3K
- Earning Date
- CNEY 01-01-0001
- HSDT 08-11-2025
- Dividend Yield
- CNEY N/A
- HSDT N/A
- EPS Growth
- CNEY N/A
- HSDT N/A
- EPS
- CNEY N/A
- HSDT N/A
- Revenue
- CNEY $50,957,974.00
- HSDT $434,000.00
- Revenue This Year
- CNEY N/A
- HSDT N/A
- Revenue Next Year
- CNEY N/A
- HSDT $75.13
- P/E Ratio
- CNEY N/A
- HSDT N/A
- Revenue Growth
- CNEY N/A
- HSDT N/A
- 52 Week Low
- CNEY $2.53
- HSDT $8.21
- 52 Week High
- CNEY $40.00
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- CNEY 42.93
- HSDT 21.43
- Support Level
- CNEY $2.59
- HSDT $8.21
- Resistance Level
- CNEY $2.84
- HSDT $10.70
- Average True Range (ATR)
- CNEY 0.17
- HSDT 2.58
- MACD
- CNEY 0.03
- HSDT 5.13
- Stochastic Oscillator
- CNEY 33.40
- HSDT 6.15
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.